Goatboy here and today I want to look at the three kits in the 40K Ork range that most need an update. GW PLEASE!
Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...
Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau antibody failed to slow clinical decline in patients with early Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback